TINA MALONSON: Open Payments
NPI 1902437270 · SLIDELL, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,198 in 120 payments from 17 companies in 2025. Trend: 2023 $539 · 2024 $2,016 · 2025 $3,198
Food & beverage: $3,198
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 27 | $606 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $529 |
| Vanda Pharmaceuticals Inc. | 12 | $397 |
| Janssen Pharmaceuticals, Inc | 20 | $339 |
| E.R. Squibb & Sons, L.L.C. | 7 | $270 |
| Otsuka America Pharmaceutical, Inc. | 10 | $154 |
| Braeburn Inc. | 3 | $138 |
| Amgen Inc. | 1 | $135 |
| Phathom Pharmaceuticals, Inc. | 1 | $124 |
| Sage Therapeutics, LLC | 1 | $100 |
Products named: Auvelity, CAPLYTA, FANAPT, SPRAVATO, COBENFY, BRIXADI, KRYSTEXXA, VOQUEZNA.
Industry payments across LA — which companies pay providers there.
